Advertisement.

PTCT Projected Dividend Yield

PTC Therapeutics Inc ( NASDAQ : PTCT )

PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of medicines. Co. has a portfolio pipeline that includes several commercial products and product candidates focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. Co. has two products, Translarna™ (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, or DMD. Translarna is designed for the treatment of nonsense mutation DMD in ambulatory patients aged two years and older Emflaza is designed for the treatment of DMD in patients two years and older.

20 YEAR PERFORMANCE RESULTS

PTCT Dividend History Detail
PTCT Dividend News
PTCT Competitors News

# of Shares: 0

Closing Price: 46.37

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000